NAGA Gene - Alpha-N-Acetylgalactosaminidase

Comprehensive gene card for NAGA, encoding alpha-N-acetylgalactosaminidase, associated with Kanzaki disease and Schindler disease.

Gene Information Card

Symbol NAGA
Full Name Alpha-N-Acetylgalactosaminidase
Gene Type Protein coding
Chromosomal Location 22q13.2
NCBI Gene ID 4668 ncbi.nlm.nih.gov/gene/4668
Ensembl ID ENSG00000100320
UniProt ID P17050
OMIM ID 104170
HGNC ID 7631
Aliases D22S674, GALN, NAGA-1, NAGA-2

Description

The NAGA gene encodes alpha-N-acetylgalactosaminidase, a lysosomal enzyme that hydrolyzes terminal alpha-N-acetylgalactosamine residues from glycoproteins and glycolipids. Mutations in NAGA cause lysosomal storage disorders, including Schindler disease (type I, II, III) and Kanzaki disease. The gene is located on chromosome 22q13.2 and is expressed in multiple tissues.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Schindler disease type I (infantile) Loss-of-function mutations in NAGA lead to deficient alpha-N-acetylgalactosaminidase activity, causing accumulation of glycoconjugates in lysosomes, resulting in severe neuroaxonal dystrophy. ClinVar, OMIM
Schindler disease type II (adult-onset) Partial enzyme deficiency due to missense mutations, leading to milder neurological symptoms and angiokeratoma. ClinVar, OMIM
Kanzaki disease Specific missense mutations (e.g., p.Glu325Lys) cause residual enzyme activity, presenting with angiokeratoma, mild intellectual disability, and peripheral neuropathy. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 15.2 Medium
Liver 12.8 Medium
Kidney 18.5 Medium
Heart 10.1 Medium
Lung 9.3 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 20.5 High expression
HeLa 14.2 Medium expression
K562 8.7 Low expression
HepG2 16.1 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.973G>A (p.Glu325Lys) Missense Common in Kanzaki disease Reduced enzyme activity, residual function
c.985C>T (p.Arg329Trp) Missense Rare Loss of function, Schindler disease
c.1078G>A (p.Gly360Arg) Missense Rare Loss of function, Schindler disease
c.1A>G (p.Met1?) Start loss Rare Complete loss of function, severe phenotype
Mutation functional classification

Loss of Function (LOF)

Most NAGA mutations result in loss of enzymatic activity, leading to substrate accumulation in lysosomes and disease.

Gain of Function (GOF)

No gain-of-function mutations reported for NAGA.

Dominant Negative (DN)

No dominant-negative mutations reported; NAGA deficiency is autosomal recessive.

Pathways

• Lysosome (KEGG: hsa04142)
• Glycosphingolipid biosynthesis - globo series (KEGG: hsa00603)
• Metabolism of glycoproteins (Reactome: R-HSA-446203)

Protein Summary

Alpha-N-acetylgalactosaminidase (NAGA) is a lysosomal exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycoproteins and glycolipids. The enzyme is a homodimer and requires no cofactors. Deficiency leads to accumulation of substrates such as sialyl-Tn antigen, causing lysosomal storage disorders. The protein is encoded by the NAGA gene on chromosome 22q13.2.

Related Products

Product name Cat.No. Species Gene ID
NAGA Knockout HEK293 Cell Line EDJ-KQ5306 Human 4668 Details Get a Quote
NAGA Knockout A-549 Cell Line EDJ-KQ28370 Human 4668 Details Get a Quote
NAGA Knockout HCT 116 Cell Line EDJ-KQ28371 Human 4668 Details Get a Quote
NAGA Knockout HeLa Cell Line EDJ-KQ28372 Human 4668 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: